Research and Markets (http://www.researchandmarkets.com/research/4c8e9f/a_global_recession) has announced the addition of Decision Resources, Inc.'s new report "A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma Industry" to their offering.
The biotechnology and pharmaceutical sectors as we know them will soon cease to exist. Companies in these sectors have come face-to-face with the harrowing ordeals of a global recession. Four stresses on the industry are rapidly depleting cash reserves, changing sources of growth, the specter of comparative effectiveness, and the threat posed by biosimilars. Staying alive in the short term and creating a more viable way of doing business are serious concerns. Many biotech companies have put themselves on ice with skeleton staffs in an attempt to ride out the recession, but they may never recover their scientific momentum. Mid-tier pharmaceutical companies are scrambling and fear for their independence. A new world order is on the horizon that will be a more unified biopharmaceutical industry. This report addresses the issues underlying the evolving nature of the biotech and mid-tier pharmaceutical sectors and identifies strategies and opportunities for moving forward.
Questions Answered in This Report